PAX3/7-FOXO1 fusions by fluorescent in situ hybridization (FISH) using an adult rhabdomyosarcoma tissue microarray. Background: Surgical management of cutaneous angiosarcoma (AS) of the head and neck ...
BUFFALO, N.Y., May 03, 2019 (GLOBE NEWSWIRE) -- Athenex, Inc. (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for ...
Angiosarcoma is the focus of two studies conducted by the newly formed Asian Sarcoma Consortium (ASC). This heterogeneous cancer has two distinct subtypes: elderly patients with scalp/cutaneous ...
BUFFALO, N.Y., May 29, 2020 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for ...
A previous version of this article appeared on Targeted Oncology ™. Although immunotherapy has become a mainstay of treatment for various types of cancer, it has been less successful in treating ...
Three-fourths of patients with advanced non-melanoma skin cancer of the head and neck achieved disease control with the oncolytic virus RP1 plus the PD-1 inhibitor nivolumab (Opdivo), a preliminary ...
The pitfall of self-reported stress levels is that the baseline stress for some people is so high, a cancer diagnosis doesn’t even register. Investigators examine survival trends for cutaneous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback